This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
ASPREE
ASPirin in reducing Events in the Elderly: an RCT of low dose aspirin
https://www.aspree.org/
[email protected]
NIH
NIH
Only through the study|Through links to medical records|Through links to other records or registers(Cancer and other registries)
Australia
No
Data made publicly available after a specified time point
No
No
No
To determine whether regular low dose aspirin extends survival free of dementia and persistent physical disability
5
John McNeil, Monash University, Methods and rationale paper for ASPREE|John McNeil, Monash University, Methods and rationale paper for ASPREE|Elsdon Storey, Monash University, Methods and rationale paper for sub-study on neurocognitive function and neuroimaging (ENVISION)
More than 15,000
Above 5,000
Neurocognitive assessments, physical and clinical criteria
No clinical disorder
Yes
death, dementia, persistent physical disability, CVD, stroke, cancer, depression, clinically significant bleeding
Randomized Controlled Trial
No
Data collection ongoing
Yes – intend to apply for funding
Data summarised in database
Database is web-based
No
No
No
No
ASPirin in reducing Events in the Elderly: an RCT of low dose aspirin
Alzheimer’s disease and other dementias|Parkinson’s disease
Case Control Studies
Australia
Alzheimer’s disease & other dementias|Parkinson’s disease & PD-related disorders
2016